MiR-627 attenuates TGFβ1-induced proliferation of normal human primary lung fibroblasts by downregulating HMGB1 and inhibiting the NF-κB pathway, thereby alleviating the development of pulmonary fibrosis [17, 23]. Here, NFKB1 is linked to pulmonary fibrosis.